Tuberculosis treatment and management-an update on treatment regimens, trials, new drugs, and adjunct therapies, Lancet Resp Med, vol.3, pp.220-234, 2015. ,
The role of pyrazinamide in tuberculosis chemotherapy, Chest, vol.94, pp.845-850, 1988. ,
Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations, Am Rev Resp Dis, vol.145, pp.1223-1225, 1992. ,
, WHO. Global tuberculosis report, 2016.
, WHO treatment guidelines for drug-resistant tuberculosis: 2016 update
Pyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis, Antimicrob Agents Chemother, vol.56, pp.5465-5475, 2012. ,
Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility, Emerg Microb Infect, vol.1, p.5, 2012. ,
Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide, J Med Microbiol, vol.51, pp.42-49, 2002. ,
Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, J Clin Microbiol, vol.48, pp.300-301, 2010. ,
Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience, Int J Tuberc Lung Dis, vol.17, pp.1486-1490, 2013. ,
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project, The Lancet infectious diseases, vol.16, pp.1185-1192, 2016. ,
Systematic analysis of pyrazinamideresistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis, Antimicrob Agents Chemother, vol.56, pp.5186-5193, 2012. ,
Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide, PLoS ONE, vol.6, p.15785, 2011. ,
Mechanisms of pyrazinamide action and resistance, Microbiol Spectr, vol.2, pp.1-12, 2013. ,
Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis, Emerg Microb Infect, vol.2, p.34, 2013. ,
Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis, Science, vol.333, pp.1630-1632, 2011. ,
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study, mBio, vol.5, pp.1819-01814, 2014. ,
Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates, Antimicrob Agents Chemother, vol.59, pp.5267-5277, 2015. ,
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis, Antimicrob Agents Chemother, vol.41, pp.540-543, 1997. ,
Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis, Tuber Lung Dis, vol.78, pp.117-122, 1997. ,
Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene, Infect Genet Evolut, vol.19, pp.1-6, 2013. ,
Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China, J Clin Microbiol, vol.52, pp.291-297, 2014. ,
Multicenter study of the emergence and genetic characteristics of pyrazinamide-resistant tuberculosis in China, Antimicrob Agents Chemother, vol.60, pp.5159-5166, 2016. ,
Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations, Diagnos Microbiol Infect Dis, vol.84, pp.207-211, 2016. ,
, Vietnam national tuberculosis control programme N. Guidline for Management of Multidrug Resistance Tuberculosis, 2009.
The fourth national anti-tuberculosis drug resistance survey in Viet Nam, Int J Tuberc Lung Dis, vol.19, pp.670-675, 2015. ,
, Guidelines for surveillance of drug resistance in tuberculosis, 2003.
Reduced turn-around time for Mycobacterium tuberculosis drug susceptibility testing with a proportional agar microplate assay, Clin Microbiol Infect, vol.21, pp.1084-1092, 2015. ,
Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J Clin Microbiol, vol.35, pp.907-914, 1997. ,
SITVITWEB-a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology, Infect Genet Evol, vol.12, pp.755-766, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00691750
Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis, J Clin Microbiol, vol.44, pp.4498-4510, 2006. ,
Tuberculosis drug resistance mutation database, PLoS Med, vol.6, p.2, 2009. ,
A global perspective on pyrazinamide resistance: systematic review and meta-analysis, PLoS One, vol.10, p.133869, 2015. ,
Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis, Antimicrob Agents Chemother, vol.58, pp.4928-4930, 2014. ,
, Emerging Microbes & Infections
Genome sequencing reveals novel deletions associated with secondary resistance to pyrazinamide in MDR Mycobacterium tuberculosis, J Antimicrob Chemotherapy, vol.70, pp.2511-2514, 2015. ,
Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, BMC Res Notes, vol.6, p.444, 2013. ,
pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal, Antimicrob Agents Chemother, vol.48, pp.2736-2738, 2004. ,
Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru, Tuber Lung Dis, vol.79, pp.111-118, 1998. ,
Selection of in vitro mutants of pyrazinamide-resistant Mycobacterium tuberculosis, Int J Antimicrob Agents, vol.20, pp.275-281, 2002. ,
Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis, Antimicrob Agents Chemother, vol.52, pp.1852-1854, 2008. ,
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil, Antimicrob Agents Chemother, vol.49, pp.444-446, 2005. ,
Sequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications: Identification of a species-specific pncA mutation in 'Mycobacterium canettii' and the reliable and rapid predictor of pyrazinamide resistance, J Clin Microbiol, vol.45, pp.595-599, 2007. ,
Characteristics of pncA mutations in multidrugresistant tuberculosis in Taiwan, BMC Infect Dis, vol.11, p.240, 2011. ,
Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China, Antimicrob Agents Chemother, vol.59, pp.1690-1695, 2015. ,
Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran, Microb Drug Resist, vol.15, pp.251-256, 2009. ,
Mycobacterium tuberculosis lineages and antituberculosis drug resistance in reference hospitals across Viet Nam, BMC Microbiol, vol.16, p.167, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02003072
Pyrazinamide resistance in Mycobacterium tuberculosis fails to bite?, Pathogens Dis, vol.73, p.37, 2015. ,
Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa, PLoS One, vol.8, p.70919, 2013. ,
Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal, PLoS Med, vol.12, p.1001880, 2015. ,